Multiple organ dysfunction syndrome
Multiple Organ Dysfunction Syndrome (MODS)
Introduction
Multiple Organ Dysfunction Syndrome (MODS) is a critical condition characterized by altered organ function in acutely ill patients, requiring medical intervention to maintain homeostasis. Notably, terminology like "multiple organ failure" or "multisystem organ failure" has been debated, with some sources preferring MODS for its precision.
Pathophysiology
MODS results from a severe, overwhelming inflammatory response to various triggers such as infection, trauma, or shock. This response leads to a cascade of events causing dysfunction in multiple organ systems.
Causes and Risk Factors
Common causes of MODS include sepsis, major surgery complications, trauma, and severe, prolonged inflammation. Patients in intensive care units (ICU) are particularly at risk.
Diagnosis
Diagnosing MODS involves evaluating the function of several organ systems. This includes assessing respiratory, cardiovascular, renal, hepatic, and neurological systems, often using specific scoring systems.
Treatment and Management
Treatment of MODS is primarily supportive and involves stabilizing vital organ functions. Strategies include fluid resuscitation, use of vasopressors, respiratory support, renal replacement therapy, and targeted pharmacological interventions.
Terminology Debate
Despite the caution against using terms like "multiple organ failure," noted medical textbooks such as Harrison's (2015) and Cecil's (2012) continue to use them. The debate reflects evolving understanding and definitions in critical care medicine.
Epidemiology
MODS is a leading cause of death in ICUs worldwide. Its incidence and mortality rates are influenced by the underlying cause, patient age, and comorbidities.
Prognosis
The prognosis of MODS varies widely, dependent on factors like the number of organs involved, the severity of dysfunction, and the patient’s overall health status.
See Also
References
<references>
- ,
Understanding Multiple Organ Dysfunction Syndrome, Journal of Intensive Care Medicine, 2018,
- ,
Harrison's Principles of Internal Medicine, McGraw Hill Education, 2015,
</references>
External Links
- National Center for Biotechnology Information - Multiple Organ Dysfunction Syndrome
- Medscape - Multiple Organ Dysfunction Syndrome
|
|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

